Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 2
2015 2
2016 2
2017 1
2018 1
2019 3
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer.
Zhang H, Christensen CL, Dries R, Oser MG, Deng J, Diskin B, Li F, Pan Y, Zhang X, Yin Y, Papadopoulos E, Pyon V, Thakurdin C, Kwiatkowski N, Jani K, Rabin AR, Castro DM, Chen T, Silver H, Huang Q, Bulatovic M, Dowling CM, Sundberg B, Leggett A, Ranieri M, Han H, Li S, Yang A, Labbe KE, Almonte C, Sviderskiy VO, Quinn M, Donaghue J, Wang ES, Zhang T, He Z, Velcheti V, Hammerman PS, Freeman GJ, Bonneau R, Kaelin WG Jr, Sutherland KD, Kersbergen A, Aguirre AJ, Yuan GC, Rothenberg E, Miller G, Gray NS, Wong KK. Zhang H, et al. Among authors: bulatovic m. Cancer Cell. 2020 Jan 13;37(1):37-54.e9. doi: 10.1016/j.ccell.2019.11.003. Epub 2019 Dec 26. Cancer Cell. 2020. PMID: 31883968 Free PMC article.
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer.
Deng J, Thennavan A, Dolgalev I, Chen T, Li J, Marzio A, Poirier JT, Peng DH, Bulatovic M, Mukhopadhyay S, Silver H, Papadopoulos E, Pyon V, Thakurdin C, Han H, Li F, Li S, Ding H, Hu H, Pan Y, Weerasekara V, Jiang B, Wang ES, Ahearn I, Philips M, Papagiannakopoulos T, Tsirigos A, Rothenberg E, Gainor J, Freeman GJ, Rudin CM, Gray NS, Hammerman PS, Pagano M, Heymach JV, Perou CM, Bardeesy N, Wong KK. Deng J, et al. Among authors: bulatovic m. Nat Cancer. 2021 May;2(5):503-514. doi: 10.1038/s43018-021-00208-6. Epub 2021 May 17. Nat Cancer. 2021. PMID: 34142094 Free PMC article. No abstract available.
Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
Ludwig G, Mojić M, Bulatović M, Mijatović S, Maksimović-Ivanić D, Steinborn D, Kaluđerović GN. Ludwig G, et al. Among authors: bulatovic m. Anticancer Agents Med Chem. 2016;16(11):1455-1460. doi: 10.2174/1871520615666151029100749. Anticancer Agents Med Chem. 2016. PMID: 26510901
Organotin(IV)-loaded mesoporous silica as a biocompatible strategy in cancer treatment.
Bulatović MZ, Maksimović-Ivanić D, Bensing C, Gómez-Ruiz S, Steinborn D, Schmidt H, Mojić M, Korać A, Golić I, Pérez-Quintanilla D, Momčilović M, Mijatović S, Kaluđerović GN. Bulatović MZ, et al. Angew Chem Int Ed Engl. 2014 Jun 2;53(23):5982-7. doi: 10.1002/anie.201400763. Epub 2014 May 14. Angew Chem Int Ed Engl. 2014. PMID: 24828572
Effect of chain length on the cytotoxic activity of (alkyl-ω-ol)triphenyltin(IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15~Cl|Ph3Sn(CH2)8OH.
Bensing C, Mojić M, Bulatović M, Edeler D, Pérez-Quintanilla D, Gómez-Ruiz S, Maksimović-Ivanić D, Mijatović S, Kaluđerović GN. Bensing C, et al. Among authors: bulatovic m. Biomater Adv. 2022 Sep;140:213054. doi: 10.1016/j.bioadv.2022.213054. Epub 2022 Jul 30. Biomater Adv. 2022. PMID: 35964389
Platinum(II/IV) complexes containing ethylenediamine-N,N'-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells.
Kaluđerović GN, Mijatović SA, Zmejkovski BB, Bulatović MZ, Gómez-Ruiz S, Mojić MK, Steinborn D, Miljković DM, Schmidt H, Stošić-Grujičić SD, Sabo TJ, Maksimović-Ivanić DD. Kaluđerović GN, et al. Among authors: bulatovic mz. Metallomics. 2012 Aug;4(9):979-87. doi: 10.1039/c2mt20058a. Metallomics. 2012. PMID: 22820831
The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K.
Maksimovic-Ivanic D, Mojic M, Bulatovic M, Radojkovic M, Kuzmanovic M, Ristic S, Stosic-Grujicic S, Miljkovic D, Cavalli E, Libra M, Fagone P, McCubrey J, Nicoletti F, Mijatovic S. Maksimovic-Ivanic D, et al. Among authors: bulatovic m. Leuk Res. 2015 Oct;39(10):1088-95. doi: 10.1016/j.leukres.2015.06.013. Epub 2015 Jun 28. Leuk Res. 2015. PMID: 26220866
15 results